Skip to main content
Clinical Trials/CTRI/2022/06/042983
CTRI/2022/06/042983
Not yet recruiting
Phase 2

Clinical study to evaluate the combined effect of Harataladi lepa and Bakuchi churna capsule in the management of Switra (Vitiligo) in children

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan

Eligibility Criteria

Inclusion Criteria

  • 1\. The children of either gender between the age group of 6\-16 years fulfilling the diagnostic criteria of Vitiligo.
  • 2\. Children, whose parents are willing to participate them in the study after giving informed parent consent.

Exclusion Criteria

  • 1\. Vitiligo patches developed as a complication of burns.
  • 2\. Children diagnosed with autoimmune disorders, neurological disorders, endocrine disorders, leprosy and tuberculosis.
  • 3\. Children with universal vitiligo and mucosal vitiligo.

Outcomes

Primary Outcomes

Not specified

Similar Trials